1. Home
  2. FRPH vs ORIC Comparison

FRPH vs ORIC Comparison

Compare FRPH & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FRP Holdings Inc.

FRPH

FRP Holdings Inc.

N/A

Current Price

$17.55

Market Cap

356.9M

Sector

Finance

ML Signal

N/A

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

N/A

Current Price

$7.39

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRPH
ORIC
Founded
1986
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
356.9M
1.4B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
FRPH
ORIC
Price
$17.55
$7.39
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
★ $21.29
AVG Volume (30 Days)
113.4K
★ 1.8M
Earning Date
11-04-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 19.67
EPS
★ N/A
N/A
Revenue
★ $42,846,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2.57
N/A
52 Week Low
$17.29
$7.23
52 Week High
$25.74
$14.68

Technical Indicators

Market Signals
Indicator
FRPH
ORIC
Relative Strength Index (RSI) 35.95 31.88
Support Level $17.29 N/A
Resistance Level $20.28 $14.23
Average True Range (ATR) 0.77 0.62
MACD -0.02 -0.05
Stochastic Oscillator 17.28 2.54

Price Performance

Historical Comparison
FRPH
ORIC

About FRPH FRP Holdings Inc.

FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, industrial, and office (the Development Segment), and (iv) management of mixed-use residential/retail properties owned through joint ventures.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: